middl
east
respiratori
syndrom
mer
caus
merscov
recent
identifi
coronaviru
sever
coronavirus
caus
upper
respiratori
tract
infect
case
also
produc
lower
respiratori
tract
infect
flulik
state
sar
coronaviru
merscov
two
pathogen
coronaviru
famili
predominantli
caus
seriou
lower
tract
respiratori
infect
high
mortal
rate
genet
differ
virus
merscov
first
identifi
follow
death
patient
saudi
arabia
seriou
respiratori
infect
find
led
retrospect
diagnosi
first
case
inhospit
outbreak
jordan
case
record
middl
east
case
saudi
arabia
case
outsid
region
affect
travel
mortal
rate
mer
approxim
inform
mer
mechan
transmiss
still
limit
like
occur
droplet
direct
indirect
contact
infect
respiratori
secret
aerosol
transmiss
rule
current
transmiss
human
limit
occasion
low
secondari
attack
rate
isol
case
record
consist
nosocomi
household
outbreak
transmiss
sustain
time
situat
major
south
korean
outbreak
origin
case
saudi
arabia
affect
peopl
adequ
infect
control
measur
healthcar
rapidli
limit
inhospit
transmiss
genet
analysi
show
human
merscov
quit
similar
viru
found
bat
essenti
ident
observ
camel
viru
appear
origin
bat
transit
camel
probabl
africa
afterward
transmit
human
serolog
studi
show
presenc
human
observ
camel
sinc
observ
suggest
camel
reservoir
viru
transmit
human
direct
contact
anim
consumpt
milk
case
diagnos
juli
death
world
health
organ
patient
male
averag
age
year
fig
children
diseas
tend
milder
asymptomat
sever
case
result
comorbid
incub
defin
period
primari
secondari
case
estim
last
averag
day
day
clinic
present
character
fever
cough
myalgia
diarrhea
diseas
wide
symptomat
spectrum
rang
asymptomat
infect
fulmin
respiratori
failur
relat
high
mortal
patient
evolv
rapidli
period
averag
respiratori
kidney
failur
requir
ventil
support
intens
care
manag
case
diagnost
confirm
achiev
viral
isol
laboratori
biosecur
clearanc
level
altern
viru
detect
respiratori
sampl
molecular
biolog
techniqu
polymeras
chain
reaction
pcr
avail
refer
laboratori
patient
display
symptom
day
determin
specif
antibodi
recommend
specif
treatment
antivir
therapi
avail
support
measur
intens
care
seriou
case
specif
prevent
vaccin
infect
suspect
everi
travel
report
travel
arabian
peninsula
past
day
also
present
respiratori
symptom
fever
sar
first
identifi
coronaviru
capabl
produc
seriou
pulmonari
diseas
unlik
previous
known
hcovoc
caus
common
cold
sar
emerg
late
china
quickli
dissemin
southeast
asia
europ
africa
america
bat
presum
reservoir
transfer
human
civet
viru
caus
great
intern
alarm
rapid
progress
serious
result
extens
rapidli
progress
pneumonia
mortal
rate
around
health
worker
particularli
affect
constant
symptom
admiss
high
fever
malais
cough
headach
follow
diarrhea
prolong
fever
case
note
caus
death
thank
intern
coordin
leadership
epidem
control
juli
five
clear
object
achiev
record
time
identif
etiolog
agent
develop
diagnost
test
viru
detect
creation
evalu
epidemiolog
treatment
protocol
reduc
morbid
mortal
definit
key
epidemiolog
paramet
control
transmiss
formul
appropri
public
health
measur
sar
demonstr
coronavirus
caus
seriou
lower
respiratori
infect
would
later
observ
hcovhku
date
new
circul
agent
proven
coronaviru
nl
belong
coronaviru
group
discov
first
time
child
bronchiol
netherland
ratifi
small
children
hospit
seriou
respiratori
infect
belong
coronaviru
group
ii
identifi
also
shown
capabl
caus
lower
respiratori
tract
infect
describ
throughout
world
prove
ubiqu
viru
detect
acut
respiratori
diseas
case
symptom
rang
upper
respiratori
diseas
includ
flulik
diseas
fever
rhiniti
odynophagia
cough
seriou
condit
rapidli
progress
respiratori
diseas
infect
children
manifest
obstruct
laryngotrach
case
comparison
children
infect
viru
first
virus
describ
elderli
patient
preexist
condit
caus
death
later
studi
consid
children
well
adult
confirm
infect
caus
coronaviru
may
worsen
health
statu
individu
underli
diseas
need
hospit
often
infect
caus
upper
respiratori
tract
symptom
fever
coryza
odynophagia
cough
wheez
pneumonia
bronchiol
may
also
present
children
greater
frequenc
feverish
convuls
observ
comparison
children
infect
virus
tend
manifest
common
cold
usual
coronavirus
nevertheless
small
children
elderli
patient
immunosuppress
patient
caus
seriou
respiratori
diseas
high
mortal
rate
influenza
viru
widespread
natur
main
reservoir
domest
feral
bird
sever
type
exist
accord
hemagglutinin
h
neuraminidas
n
makeup
two
recent
circul
among
human
caus
season
outbreak
anim
reservoir
viru
larg
vari
sever
subtyp
describ
includ
hemagglutinin
neuraminidas
type
zoonot
virus
may
caus
diseas
infect
sever
anim
gener
pig
poultri
zoonot
virus
particular
adapt
poorli
human
seldom
caus
human
diseas
limit
outbreak
circumscrib
term
time
popul
nevertheless
human
case
observ
hong
kong
first
time
continu
report
date
case
notifi
asia
northern
africa
death
case
isol
intrafamili
cluster
describ
humantohuman
transmiss
rare
reflect
poor
abil
viru
adapt
human
respiratori
mucosa
persist
circul
virus
great
genet
variabl
influenza
viru
make
us
fear
avian
viru
may
adapt
human
would
eas
transmiss
among
human
popul
potenti
caus
pandem
happen
influenza
porcin
origin
adapt
human
creat
pandem
first
case
human
infect
caus
influenza
report
china
relat
one
way
anoth
contact
poultri
whether
direct
environment
market
live
bird
commerci
confirm
influenza
case
china
sinc
begin
outbreak
death
viru
seem
spread
easili
among
human
proof
sustain
human
transmiss
although
transmiss
potenti
seem
effect
influenza
viru
coupl
case
report
outsid
china
travel
malaysia
stay
china
man
wife
diagnos
canada
januari
travel
china
record
secondari
case
countri
confirm
low
probabl
humantohuman
transmiss
case
observ
coldest
season
china
decemb
februari
new
case
diagnos
averag
age
year
death
newli
diagnos
patient
male
patient
direct
contact
poultri
market
incub
period
day
day
even
though
mild
case
describ
diagnos
seriou
mortal
rate
close
hospit
patient
febril
diseas
temperatur
cough
diseas
progress
swiftli
moder
sever
contrast
human
season
influenza
patient
report
rhinorrhea
odynophagia
set
hospit
patient
diseas
progress
swiftli
averag
day
onset
count
begin
symptom
hospit
almost
requir
invas
mechan
ventil
death
rate
death
respiratori
failur
reach
caus
septic
shock
death
correspond
elderli
patient
underli
diseas
well
use
system
steroid
diagnosi
perform
identifi
viral
rna
rtpcr
respiratori
tract
sampl
obtain
swab
nasal
suction
well
avian
influenza
viru
viru
sensit
oseltamivir
resist
adamantin
oseltamivir
indic
hospit
ambulatori
patient
whether
confirm
suspicion
infect
influenza
even
h
pass
sinc
onset
symptom
dosag
timefram
therapi
clearli
establish
seriou
patient
longer
timefram
suggest
around
day
higher
dose
patient
mild
noncompl
infect
therapi
must
continu
day
patient
mild
infect
requir
ambulatori
treatment
whose
exposur
factor
travel
area
record
case
human
bird
empir
indic
oseltamivir
isol
case
avian
origin
human
caus
influenza
viru
observ
china
fact
prove
zoonot
influenza
case
vigil
extrem
import
given
pandem
potenti
crucial
pay
close
attent
travel
enforc
local
vigil
new
viru
bunyavirida
famili
identifi
unit
state
america
name
viru
name
deem
respons
known
cardiopulmonari
hantaviru
syndrom
cardiopulmonar
por
hantaviru
scph
feverish
diseas
character
respiratori
insuffici
shock
discoveri
new
zoonosi
practic
extend
next
year
across
whole
american
contin
process
new
clinic
manifest
recogn
new
agent
identifi
includ
and
laguna
negra
araquara
choclo
virus
preval
chile
argentina
paraguay
brazil
panama
respect
natur
reservoir
sigmondontina
rodent
belong
murida
famili
anim
develop
chronic
infect
intermitt
viral
asymptomat
excret
stress
situat
lack
food
birth
period
cold
habitat
intervent
log
associ
greater
viru
excret
rodent
mice
excret
viru
fece
urin
saliva
contamin
environ
repres
viruscarri
rodent
peromyscu
maniculatu
deer
mous
carri
nonam
viru
oligoryzomi
longicaudatu
longtail
mous
calomi
laucha
among
other
human
acquir
infect
inhal
secret
stool
urin
saliva
infect
rodent
and
viru
predomin
southern
argentina
singl
causal
agent
chile
transmit
close
humantohuman
contact
hantavirus
spheric
virus
triseg
rna
genom
lipid
envelop
two
glycoprotein
gn
gc
protrud
three
segment
code
protein
rna
polymeras
l
segment
glycoprotein
gn
gc
segment
import
recognit
integrin
viru
use
receptor
nucleoprotein
segment
highli
conserv
protein
use
laboratori
diagnosi
agent
lipid
envelop
sensit
destroy
deterg
chlorid
desicc
sun
exposur
action
form
basi
prevent
control
recommend
hantaviru
infect
agent
enter
respiratori
tract
inhal
aerosol
viru
environ
contamin
human
secret
incub
period
rang
week
day
averag
nonspecif
symptom
begin
includ
fever
myalgia
headach
plu
digest
symptom
common
children
stage
follow
progress
respiratori
diseas
final
respiratori
failur
seriou
manifest
infect
case
acut
infect
viru
present
white
cell
variabl
proport
plasma
respiratori
secret
saliva
urin
also
viral
rna
detect
white
cell
day
day
first
symptom
interact
integrin
replic
viral
endotheli
cell
variou
tissu
appear
alter
modul
function
permeabl
cell
especi
increas
permeabl
small
lung
vessel
favor
arteri
hypotens
thrombocytopenia
hypoxia
plasma
flood
alveolar
space
protein
n
superfici
glycoprotein
stimul
product
specif
neutral
antibodi
associ
better
surviv
outcom
increas
prematur
patient
progress
cardiopulmonari
phase
respiratori
failur
set
requir
supplementari
oxygen
addit
two
third
need
mechan
ventil
patient
develop
cardiogen
shock
constitut
poor
prognosi
factor
increas
vascular
rate
explain
pulmonari
edema
observ
stage
function
alter
transitori
last
h
afterward
pulmonari
function
quickli
recov
follow
brief
period
notic
diuresi
cardiogen
shock
difficult
manag
main
caus
death
lethal
hanta
cardiopulmonari
syndrom
death
occur
first
h
evolut
hemogram
use
gener
laboratori
test
hypothes
diagnosi
earli
stage
reveal
manifest
reduct
number
platelet
well
presenc
lymphocyt
take
shape
immunoblast
late
onset
hematocrit
increas
observ
concomit
begin
cardiopulmonari
phase
diseas
also
help
test
ldh
transaminas
increas
nonspecif
chest
xray
may
chang
matter
hour
nonspecif
interstiti
pattern
diffus
pulmonari
edema
virolog
diagnosi
confirm
rtpcr
white
cell
elisa
detect
specif
igmigg
region
viru
current
specif
treatment
hantaviru
infect
cardiopulmonari
support
patient
monitor
close
prefer
intens
care
unit
provid
measur
mechan
ventil
breath
support
restrict
liquid
vasoact
drug
use
antivir
ribavirin
shown
effect
treatment
extracorpor
membran
oxygen
ecmo
use
rescu
therapi
case
seriou
cardiopulmonari
failur
respond
convent
ventil
vasoact
drug
chile
two
therapeut
option
investig
hantaviru
methylprednisolon
high
dose
immun
plasma
high
neutral
antibodi
titer
latter
strategi
shown
promis
result
rel
mortal
rate
reduct
use
immedi
symptom
onset
control
measur
hospit
patient
manag
consid
hantaviru
describ
capabl
caus
nosocomi
transmiss
standard
precaut
must
taken
ideal
intern
patient
individu
room
wear
protect
equip
apron
glove
face
mask
high
effici
filter
secur
glass
especi
procedur
close
contact
patient
fluid
intub
secret
suction
retriev
sampl
laboratori
test
viral
agent
enteroviru
known
sinc
isol
children
suffer
bronchiol
pneumonia
wide
avail
trial
conduct
much
known
epidemiolog
clinic
manifest
fall
missouri
illinoi
hospit
report
unusu
rise
number
seriou
case
children
without
background
obstruct
diseas
present
acut
respiratori
infect
enteroviru
detect
patient
appli
molecular
biolog
techniqu
respiratori
sampl
infect
frequent
schoolag
children
whose
relev
clinic
anteced
presenc
previou
persist
cough
asthma
wheez
episod
may
requir
intens
care
unit
icu
manag
virul
agent
impress
enterovirus
consid
also
identifi
causal
agent
obstruct
episod
previous
healthi
children
treat
antiasthma
therapi
respond
adequ
hospit
intens
care
hypoxemia
except
receiv
mechan
ventil
common
laboratori
find
high
total
neutrophil
chest
xray
show
peribronchi
interstiti
infiltr
hyperinsuffl
atelectasi
diagnost
test
improv
sensit
specif
use
becom
widespread
pediatr
center
understand
epidemiolog
pathogeni
viral
agent
increas
two
polyomavirus
respiratori
tropism
discov
deep
sequenc
sampl
taken
respiratori
secret
symptomat
patient
polyomavirus
ki
kipyv
wu
wupyv
virus
found
lower
upper
respiratori
tract
immunocompet
well
immunocompromis
patient
pathogen
role
complet
clear
usual
occur
low
frequenc
low
viral
load
relat
pathogen
whose
morbid
better
character
diagnosi
requir
molecular
techniqu
realtim
pcr
whose
inclus
futur
research
allow
us
better
character
epidemiolog
clinic
spectrum
infect
caus
agent
